NICE is participating in the ROADMAP initiative, which is working on a sustainable platform for “real world” evidence generation concerning Alzheimer’s Disease and (hopefully) faster development of disease-modifying drugs.
“The IMI (Innovative Medicines Initiative) is Europe’s largest public-private partnership, aiming to speed up the development of better and safer medicines for patients. ROADMAP is the first in a suite of projects that are part of the IMI’s Big Data for Better Outcomes Programme. ROADMAP has a budget of €7.7 million, distributed among 22 partners from the private, academic, and public sectors”.
NICE takes key role in new European project for faster access to Alzheimer’s disease drugs: patients’ priorities will be brought to the fore in new Alzheimer’s project. [Online]: National Institute for Health and Care Excellence (NICE), January 5th 2017.